Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays.

Many assays have been developed for the detection of influenza virus which is an important respiratory pathogen. Development of these assays commonly involves the use of human clinical samples for validation of their performance. However, clinical samples can be difficult to obtain, deteriorate over...

Full description

Bibliographic Details
Main Authors: Michael E Bose, Kate C McCaul, Hong Mei, Amy Sasman, Jie He, William Kramp, Roxanne Shively, Ke Yan, Kelly J Henrickson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5117718?pdf=render
_version_ 1828858334580572160
author Michael E Bose
Kate C McCaul
Hong Mei
Amy Sasman
Jie He
William Kramp
Roxanne Shively
Ke Yan
Kelly J Henrickson
author_facet Michael E Bose
Kate C McCaul
Hong Mei
Amy Sasman
Jie He
William Kramp
Roxanne Shively
Ke Yan
Kelly J Henrickson
author_sort Michael E Bose
collection DOAJ
description Many assays have been developed for the detection of influenza virus which is an important respiratory pathogen. Development of these assays commonly involves the use of human clinical samples for validation of their performance. However, clinical samples can be difficult to obtain, deteriorate over time, and be inconsistent in composition. The goal of this study was to develop a simulated respiratory secretion (SRS) that could act as a surrogate for clinical samples. To this end, we determined the effects major respiratory secretion components (Na+, K+, Ca2+, cells, albumin IgG, IgM, and mucin) have on the performance of influenza assays including both nucleic acid amplification and rapid antigen assays. Minimal effects on the molecular assays were observed for all of the components tested, except for serum derived human IgG, which suppressed the signal of the rapid antigen assays. Using dot blots we were able to show anti-influenza nucleoprotein IgG antibodies are common in human respiratory samples. We composed a SRS that contained mid-point levels of human respiratory sample components and studied its effect compared to phosphate buffered saline and virus negative clinical sample matrix on the Veritor, Sofia, CDC RT-PCR, Simplexa, cobas Liat, and Alere i influenza assays. Our results demonstrated that a SRS can interact with a variety of test methods in a similar manner to clinical samples with a similar impact on test performance.
first_indexed 2024-12-13T01:55:46Z
format Article
id doaj.art-c4f1b942bb544dd59ca834c53f2b069a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T01:55:46Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c4f1b942bb544dd59ca834c53f2b069a2022-12-22T00:03:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011111e016680010.1371/journal.pone.0166800Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays.Michael E BoseKate C McCaulHong MeiAmy SasmanJie HeWilliam KrampRoxanne ShivelyKe YanKelly J HenricksonMany assays have been developed for the detection of influenza virus which is an important respiratory pathogen. Development of these assays commonly involves the use of human clinical samples for validation of their performance. However, clinical samples can be difficult to obtain, deteriorate over time, and be inconsistent in composition. The goal of this study was to develop a simulated respiratory secretion (SRS) that could act as a surrogate for clinical samples. To this end, we determined the effects major respiratory secretion components (Na+, K+, Ca2+, cells, albumin IgG, IgM, and mucin) have on the performance of influenza assays including both nucleic acid amplification and rapid antigen assays. Minimal effects on the molecular assays were observed for all of the components tested, except for serum derived human IgG, which suppressed the signal of the rapid antigen assays. Using dot blots we were able to show anti-influenza nucleoprotein IgG antibodies are common in human respiratory samples. We composed a SRS that contained mid-point levels of human respiratory sample components and studied its effect compared to phosphate buffered saline and virus negative clinical sample matrix on the Veritor, Sofia, CDC RT-PCR, Simplexa, cobas Liat, and Alere i influenza assays. Our results demonstrated that a SRS can interact with a variety of test methods in a similar manner to clinical samples with a similar impact on test performance.http://europepmc.org/articles/PMC5117718?pdf=render
spellingShingle Michael E Bose
Kate C McCaul
Hong Mei
Amy Sasman
Jie He
William Kramp
Roxanne Shively
Ke Yan
Kelly J Henrickson
Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays.
PLoS ONE
title Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays.
title_full Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays.
title_fullStr Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays.
title_full_unstemmed Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays.
title_short Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays.
title_sort simulated respiratory secretion for use in the development of influenza diagnostic assays
url http://europepmc.org/articles/PMC5117718?pdf=render
work_keys_str_mv AT michaelebose simulatedrespiratorysecretionforuseinthedevelopmentofinfluenzadiagnosticassays
AT katecmccaul simulatedrespiratorysecretionforuseinthedevelopmentofinfluenzadiagnosticassays
AT hongmei simulatedrespiratorysecretionforuseinthedevelopmentofinfluenzadiagnosticassays
AT amysasman simulatedrespiratorysecretionforuseinthedevelopmentofinfluenzadiagnosticassays
AT jiehe simulatedrespiratorysecretionforuseinthedevelopmentofinfluenzadiagnosticassays
AT williamkramp simulatedrespiratorysecretionforuseinthedevelopmentofinfluenzadiagnosticassays
AT roxanneshively simulatedrespiratorysecretionforuseinthedevelopmentofinfluenzadiagnosticassays
AT keyan simulatedrespiratorysecretionforuseinthedevelopmentofinfluenzadiagnosticassays
AT kellyjhenrickson simulatedrespiratorysecretionforuseinthedevelopmentofinfluenzadiagnosticassays